Oncology

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Oncology

Expand your Oncology research content today with Taylor & Francis

Meet industry challenges by getting the right information at the right time.  Produce the next pharmaceutical breakthrough by giving your team access to a collection of journals filled with the most relevant and up to date research. 

Below you will find our key Oncology journals that share innovative data to physicians, medical researchers, and healthcare professionals around the world. 

Acta Oncologica

2020 Impact Factor 4.089
Five-Year Impact Factor 4.236

Publishes research into oncology, covering the etiology and treatment for all cancer types as well as experimental and clinical cancer research. 

For a limited time, we're offering you free access* to our most viewed articles from Acta Oncologica

Visit Journal Subscribe

Cancer Biology & Therapy

2020 Impact Factor 4.742
Five-Year Impact Factor 4.342

Publishes articles on the molecular basis of cancer, including translational diagnostic relevance or therapy, reviews, op-ed pieces and meeting reports.

For a limited time, we're offering you free access* to our most viewed articles from Cancer Biology & Therapy

Visit Journal Subscribe


 

Expert Review of Anticancer Therapy

2020 Impact Factor 4.512
Five-Year Impact Factor 3.665

Provides expert appraisal in cancer care, including tumor management, novel therapies, anticancer agents, chemotherapy, cancer vaccines, and biomarkers.

For a limited time, we're offering you free access* to our most viewed articles from Expert Review of Anticancer Therapy

Visit Journal Subscribe

International Journal of Hyperthermia

2020 Impact Factor 3.914
Five-Year Impact Factor 4.285

Publishes articles on various aspects of thermal energy and thermal therapy in clinical, biological or engineering studies involving human or animals.

For a limited time, we're offering you free access* to our most viewed articles from the International Journal of Hyperthermia

Visit Journal Subscribe


*When accessed via this page only. Applicable to non Open access content only.

Latest tweets from @tandfonline

SHARE THIS PAGE